SHEEL BIOTECH LIMITED Fair Value
SHEEL · Commercial Services · Current price ₹70.25
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹63 | 13% ROE fading to 12% over ~3 yrs, on ₹62 book |
| Relative P/E | ₹152 | EPS × 26.3 peer-median P/E |
| Graham floor | ₹90 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is SHEEL BIOTECH LIMITED undervalued?
DocStoX estimates the fair value of SHEEL BIOTECH LIMITED at ₹92 per share, versus the current market price of ₹70. That puts the stock about +31.3% below our fair-value estimate, which we read as "Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹63), Relative P/E (₹152), Graham floor (₹90). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹63 (bear) to ₹92 (base) to ₹152 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on SHEEL BIOTECH LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.